why choose us

First received: March 18, 2026

Clinical Trial: A Tailored Polygenic Risk Score for Predicting Progression in Prostate Cancer Under Active Surveillance

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Prostate Cancer

Study Type: OBSERVATIONAL


Official Title: A Tailored Polygenic Risk Score for Predicting Progression in Prostate Cancer Under Active Surveillance

Brief Summary: Prostate cancer is the most common malignancy in men, and in patients with low-risk disease, active surveillance represents the preferred initial approach to avoid unnecessary treatments.However, up to 50% of men under active surveillance develop clinical progression or histological upgrading within five years, making improved risk stratification essential.A family history of prostate cancer is a well-established risk factor and reflects the importance of genetic predisposition.Genome-wide studies have identified…

Read more